14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Fri, 3 May 2024

ZGNX Predictions History

2 years ago
Matthew Crawley predicted that ZGNX for 2022-01-21 is going

Rank:

4 years ago
JS predicted that ZGNX for 2020-02-10 is going $36.15 (20.86%)

4 years ago
2poJeff predicted that ZGNX for 2020-02-10 is going $32.59 (1.46%)

4 years ago
Drew.Hagen.6394 predicted that ZGNX for 2020-02-10 is going

Rank:

4 years ago
Tim F predicted that ZGNX for 2020-02-10 is going

Rank:

5 years ago
NameNotImportant predicted that ZGNX for 2019-05-03 is going $43.87 (15.39%)

5 years ago
NameNotImportant predicted that ZGNX for 2019-04-29 is going $37.45 (-3.68%)

5 years ago
NameNotImportant predicted that ZGNX for 2019-04-24 is going $36.95 (-2.92%)

5 years ago
Omer.Faruk.101585 predicted that ZGNX for 2019-03-11 is going $65.00 (27.58%)

Rank:

5 years ago
Omer.Faruk.101585 predicted that ZGNX for 2019-03-04 is going $58.75 (8.90%)

Rank:
Click to get the best stock tips daily for free!

About Zogenix

Zogenix Zogenix, Inc., a pharmaceutical company, develops and commercializes therapies for the treatment of central nervous system disorders in the United States. The company’s lead product candidate is the ZX008, a low-dose fenfluramine for the treatment of seizures associated with Dravet syndrome. It also develops Relday, an injectable formulation of risperidone that is in Phase III clinical trial to treat the symptoms of schizophrenia and bipolar dis... ZGNX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT